BPI
PCVX icon

BFC Planning, Inc.’s Vaxcyte PCVX Stock Holding History

BFC Planning, Inc.’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16K Hold
20
– – ﹤0.01% 3117
2026
Q1 		$1.16K Buy
20
+8
+67% +$434 ﹤0.01% 2716
2025
Q4 		$554 Sell
12
-34
-74% -$1.52K ﹤0.01% 2911
2025
Q3 		$1.66K Sell
46
-12
-21% -$398 ﹤0.01% 2526
2025
Q2 		$1.88K Buy
58
+20
+53% +$656 ﹤0.01% 2322
2025
Q1 		$1.44K Buy
38
+34
+850% +$2.72K ﹤0.01% 2377
2024
Q4 		$327 Buy
+4
New +$397 ﹤0.01% 2502

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BFC Planning, Inc.'s PCVX Position: Q2 2026 in Review

BFC Planning, Inc. held its Vaxcyte (PCVX) position steady in Q2 2026 at 20 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #3117.

BFC Planning, Inc. first reported a position in PCVX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.88K in Q2 2025. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • BFC Planning, Inc. held 20 shares of Vaxcyte worth $1.16K as of Q2 2026.
  • BFC Planning, Inc. left its Vaxcyte share count unchanged in Q2 2026.
  • Vaxcyte made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #3117 holding.
  • BFC Planning, Inc. first reported a position in Vaxcyte in Q4 2024 and has held it in 7 quarters since.
  • BFC Planning, Inc.'s Vaxcyte position peaked at $1.88K in Q2 2025.
  • 332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.